- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.02. | SciBase's Nevisense (EIS) Included in the US NCCN Guidelines for Melanoma which supports the use of EIS in the detection of melanoma | 223 | PR Newswire | STOCKHOLM, Feb. 19, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that Nevisense... ► Artikel lesen | |
| 17.02. | SCIBASE: A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns | 2 | Cision News | ||
| 17.02. | Scibase Holding AB: A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns | 450 | GlobeNewswire (Europe) | STOCKHOLM, Sweden - February 17, 2026 - SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of AI-based diagnostic solutions for skin disorders, announces that results from a new study will... ► Artikel lesen | |
| 06.02. | SciBase: Recalculation of warrants of series TO 2 following rights issue and updated last day of trading in BTA from the rights issue | 260 | PR Newswire | STOCKHOLM, Feb. 6, 2026 /PRNewswire/ -- In accordance with the terms and conditions for warrants of series TO 2, which were issued in connection with the capital raise announced in April... ► Artikel lesen | |
| 27.01. | SciBase announces final outcome of the rights issue and the resolution on a set-off issue within the framework of the offer to repurchase outstanding warrants of series TO 2 | 302 | PR Newswire | STOCKHOLM, Jan. 27, 2026 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the final outcome of the rights issue of shares resolved by the Company on... ► Artikel lesen | |
| SCIBASE Aktie jetzt für 0€ handeln | |||||
| 27.01. | Scibase Holding AB: SciBase announces final outcome of the rights issue and the resolution on a set-off issue within the framework of the offer to repurchase outstanding warrants of series TO 2 | 139 | GlobeNewswire (Europe) | SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the final outcome of the rights issue of shares resolved by the Company on 29 December 2025 (the "Rights Issue"). The Rights Issue... ► Artikel lesen | |
| 26.01. | SciBase: Change of date for publication of the year-end report for the financial year 2025 | 251 | PR Newswire | STOCKHOLM, Jan. 26, 2026 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has resolved to postpone the publication of the year-end report for... ► Artikel lesen | |
| 22.01. | Increased commitment in SciBase rights issue | 222 | PR Newswire | STOCKHOLM, Jan. 22, 2026 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, announces it has been informed... ► Artikel lesen | |
| 09.01. | SciBase publishes information document regarding rights issue | 356 | PR Newswire | STOCKHOLM, Jan. 9, 2026 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") publishes information documents in connection with the rights issue... ► Artikel lesen | |
| 09.01. | SciBase announces outcome of the offer to repurchase outstanding warrants of series TO 2 | 302 | PR Newswire | STOCKHOLM, Jan. 9, 2026 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the outcome of the repurchase offer for all warrants of series TO 2 resolved... ► Artikel lesen | |
| 06.01. | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.01.2026 | 450 | Xetra Newsboard | Das Instrument NW1 SE0017131865 WINDON ENERGY GROUP AB EQUITY wird cum Kapitalmassnahme gehandelt am 06.01.2026 und ex Kapitalmassnahme am 07.01.2026 The instrument NW1 SE0017131865 WINDON ENERGY GROUP... ► Artikel lesen | |
| 29.12.25 | The Board of Directors of SciBase resolves on a previously communicated rights issue of shares of approximately SEK 83 million | 726 | PR Newswire | STOCKHOLM, Dec. 29, 2025 /PRNewswire/ -- The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today, based on the authorization granted by the Annual General... ► Artikel lesen | |
| 11.12.25 | SciBase Expands Its Intellectual Property Portfolio to include the analysis of the epithelial skin barrier with New European Patent | 332 | PR Newswire | STOCKHOLM, Dec. 11, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of AI-based diagnostic solutions for skin disorders, announces that it has been granted... ► Artikel lesen | |
| 05.12.25 | SciBase publishes information document regarding the offer to repurchase outstanding warrants of series TO 2 | 447 | PR Newswire | STOCKHOLM, Dec. 5, 2025 /PRNewswire/ -- SciBase Holding AB (publ) ("SciBase" or the "Company") publishes an information document in connection with the offer to repurchase all outstanding... ► Artikel lesen | |
| 05.12.25 | Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) | 276 | PR Newswire | STOCKHOLM, Dec. 5, 2025 /PRNewswire/ -- Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance... ► Artikel lesen | |
| 05.12.25 | Scibase Holding AB: Bulletin from the extraordinary general meeting in SciBase Holding AB (publ) | 270 | GlobeNewswire (Europe) | Today, an extraordinary general meeting has been held in SciBase Holding AB (publ) ("SciBase" or the "Company"). The general meeting resolved in accordance with the proposal presented in the notice... ► Artikel lesen | |
| 21.11.25 | SCIBASE: The exercise price for warrants of series TO 3 has been determined | 2 | Cision News | ||
| 07.11.25 | SciBase: Interim report | 297 | PR Newswire | STOCKHOLM, Nov. 7, 2025 /PRNewswire/ --
January 1 - September 30, 2025
The third quarter in figures
Net sales were TSEK 10,339 (8,408), +23%, cleared... ► Artikel lesen | |
| 07.11.25 | The Board of Directors in SciBase resolves on an offer to repurchase outstanding warrants of series TO 2 and intends to resolve on a rights issue of shares of approximately SEK 83 million | 341 | PR Newswire | STOCKHOLM, Nov. 7, 2025 /PRNewswire/ -- The Board of Directors in SciBase Holding AB (publ) ("SciBase" or the "Company") has today resolved to make a repurchase offer for all 498,534... ► Artikel lesen | |
| 07.11.25 | SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million | 395 | PR Newswire | STOCKHOLM, Nov. 7, 2025 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of AI-based diagnostic solutions for skin disorders, today announced that SciBase... ► Artikel lesen |
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ROKU | 82,43 | -1,01 % | Roku Swings To Q4 Profit | WASHINGTON (dpa-AFX) - Roku, Inc. (ROKU) on Thursday reported fourth-quarter net income of $80.5 million or $0.53 per share, compared to a net loss of $35.5 million or $0.24 per share last year.Revenues... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,082 | -4,68 % | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Warrant Amendments | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - February 20, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH0) ("the Company"), a leading regenerative medicine company... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 64,60 | -0,92 % | BOSTON SCIENTIFIC CORP - S-4, Registration of securities, business combinations | ||
| PAUL HARTMANN | 215,00 | 0,00 % | Im Krankenhaus auf Aktiensuche: Paul Hartmann, Technogym und Intuitive Surgical | Ein paar Dinge habe ich nach meinen Krankenhaus-Aufenthalten im November, Dezember und Januar gelernt...
...zum Beispiel: Es ist egal, wie schlecht es dir geht, es geht immer noch jemandem schlechter... ► Artikel lesen | |
| SYSMEX | 8,000 | +1,27 % | Sysmex Corporation Bottom Line Drops In Nine Months | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) announced a profit for nine months that Dropped, from the same period last yearThe company's earnings came in at JPY33.694 billion, or JPY54.05... ► Artikel lesen | |
| ADDLIFE | 14,310 | 0,00 % | AddLife AB: Year-end report January 1 - December 31, 2025 | Continued positive margin development, strong profit and cash flow"The EBITA margin continues to develop positively and profits are growing. The strong cash flow means that our ambition to reduce the... ► Artikel lesen | |
| EMBECTA | 8,600 | -1,15 % | Dividendenbekanntmachungen (27.02.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACNB CORPORATION US0008681092 0,38 USD 0,322 EUR AGNC INVESTMENT CORP US00123Q1040 0,12 USD 0,1017 EUR AGREE REALTY CORPORATION US0084921008 0... ► Artikel lesen | |
| ENOVIS | 21,800 | +0,93 % | Enovis Corporation: Update: Enovis Announces Fourth Quarter and Full Year 2025 Results | Continued commercial momentum with full year 2025 sales growth of 7% on a reported basis and 6% organically Full year 2025 Reconstructive sales grew 10% Y/Y on a reported basis and 8% on an organic... ► Artikel lesen | |
| PULMONX | 1,320 | -1,49 % | Healthcare Rally: Pulmonx, UHS, And X4 Lead After-Hours Gains Amid Strategic Updates | WASHINGTON (dpa-AFX) - Several healthcare and biotech stocks posted notable gains in after-hours trading on Monday, driven by earnings updates, executive appointments, and capital market activity.Pulmonx... ► Artikel lesen | |
| SI-BONE | 13,400 | +2,29 % | Smith & Nephew Plc: Smith+Nephew signs distribution agreement with SI-BONE | Trauma and Extremities partnership aligns disciplined approach to portfolio optimization and focuses on delivering long-term value for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global... ► Artikel lesen | |
| REVITALIST LIFESTYLE AND WELLNESS | 0,015 | -100,00 % | Revitalist Lifestyle and Wellness Ltd: Revitalist Lifestyle CEO Walker, CFO Murray resign | ||
| KOOTH | 1,330 | 0,00 % | Kooth grants options to executives under long-term incentive plan | ||
| PEIJIA MEDICAL | 0,615 | +1,65 % | Peijia Medical Submits EU MDR CE Mark Registration Application for GeminiOne TEER System | HONG KONG, Feb. 9, 2026 /PRNewswire/ -- Peijia Medical Limited (HKEX: 9996) today announced that it has formally submitted the European Union Medical Device Regulation (EU MDR) CE Mark registration... ► Artikel lesen | |
| LIFECARE ASA | 0,026 | -42,73 % | Lifecare ASA: Exercise price for Warrants Series 1 issued in connection with the Rights Issue | ||
| BACTIGUARD | 1,310 | -2,60 % | Bactiguard Holding AB: Bactiguard Holding AB's year-end report 2025 | A year of strategic execution concluded with a strong Q4
Fourth quarter 2025 (October - December)
Total revenue amounted to SEK 65.6 (68.3) million, a decrease of SEK 2.7 million corresponding to... ► Artikel lesen |
SCIBASE HOLDING AB gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,000 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SCIBASE HOLDING AB finden Sie auf Wallstreet Online.